Synthesis and bioactivity of amino acid derivatives. I. Phenylalanine derivatives (author's transl)

DOI: 10.1248/yakushi1947.98.7_869

Source and publish data:

Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan p. 869 - 879 (1978)

Update date:2022-08-04

Topics:

Authors:

Takemura

Terauchi

Kowata Kowata

Nakano Nakano

Okumura Okumura

Inamori Inamori

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/yakushi1947.98.7_869

Full text of DOI:10.1248/yakushi1947.98.7_869

NII-Electronic Library Service

Products guided by the article

Product name:N-Glycyl-hydrazobenzol*Hydrochlorid

Cas No:68715-07-1

R&D Labs maybe for 68715-07-1

Xiamen Goodhealth Pharmchem Co., Ltd.

Contact:0086-592-2097683

Address:404R No.2 54# Minzu Rd., Xiamen, China
Zibo Fuxi'er Chemical Co.,Ltd （Shanxian Fuxi'er Chemical Co.,Ltd）

Contact:+86-533-2091422

Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD

website:http://www.xypharm.com/

Contact:+86-515-84383317

Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Shanghai Topchem Co., LTD

website:http://www.shtopchem.com/

Contact:0086-0576-87776998

Address:room no 1608,xuhui business building yude road,xujiahui street, xuhui district
Hubei Onward Bio-Development Co., Ltd.

Contact:+86-718-8417012

Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002

Relevant to this article

Doi:10.1021/ja00492a050
(1978)
Support-Free Pd₃Co NCs as an Efficient Heterogeneous Nanocatalyst for New Organic Transformations of C?C Coupling Reactions

Doi:10.1002/chem.201901834
(2019)
Synthesis, characterization, lipophilicity and cytotoxic properties of novel bis(carboxylato)oxalatobis(1-propylamine)platinum(IV) complexes

Doi:10.1016/j.ica.2019.03.036
(2019)
The effect of universal fluorinated nucleobases on the catalytic activity of ribozymes

Doi:10.1081/NCN-120022962
(2003)
First enzymatically activated Taxotere prodrugs designed for ADEPT and PMT

Doi:10.1016/j.bmc.2003.12.013
(2004)
Doi:10.1007/BF00777782
()

Article Doi